🇺🇸 FDA
Patent

US 9180212

β-amyloid plaque imaging agents

granted A61KA61K51/04

Quick answer

US patent 9180212 (β-amyloid plaque imaging agents) held by The Regents of the University of California expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K51/04